- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 11 Greenway Plaza, Suite 1000 Houston TX United States of America 77046
- IPO Date
- Dec 8, 2010
- Business
- Invesco S&P MidCap 400 GARP ETF (GRPM) is an exchange-traded fund that seeks to track the performance of the S&P MidCap 400 GARP Index by investing at least 90% of its total assets in securities comprising the index; the underlying index measures mid-cap U.S. companies exhibiting consistent fundamental growth, reasonable valuations, solid financial strength, and strong earning power, with semiannual rebalancing after market close on the third Friday of June and December. The fund provides exposure to a portfolio of approximately 59 holdings, including top positions such as Celsius Holdings Inc. (3.94%), Comfort Systems USA Inc. (2.83%), AppFolio Inc. (2.77%), Medpace Holdings Inc. (2.69%), and Halozyme Therapeutics Inc. (2.50%), with sector allocations led by financials (27.23%), consumer discretionary (17.06%), health care (12.65%), information technology (12.62%), and energy (11.07%). Launched on December 3, 2010, with headquarters aligned to its issuer Invesco Ltd. in Atlanta, Georgia, the ETF primarily targets U.S. investors through listings on NYSE Arca and features a total expense ratio of 0.35%, a CUSIP of 46137V225, and geographic focus predominantly in the United States (95.62%), with minor exposures to Bermuda (2.30%) and Thailand (2.08%).
In recent years, GRPM underwent a significant reorganization on April 6, 2018, transitioning from its Guggenheim predecessor fund while maintaining historical performance continuity, though Invesco remains unaffiliated with Guggenheim. The underlying index shifted methodologies multiple times, initially reflecting the Russell MidCap Equal Weight Index prior to January 26, 2016, then the S&P MidCap 400 Equal Weighted Index until August 25, 2023, before adopting the current S&P MidCap 400 GARP Index framework. As of September 30, 2025, the fund reported assets under management approximating $442 million to $494 million, ongoing quarterly distributions (e.g., $0.48833 per share ex-date June 23, 2025), and year-to-date NAV performance of 8.36%, underscoring its role in the mid-cap growth-at-a-reasonable-price segment amid sustained market volatility.